1. Home
  2. MATW vs ANNX Comparison

MATW vs ANNX Comparison

Compare MATW & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

N/A

Current Price

$19.29

Market Cap

639.2M

ML Signal

N/A

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$4.05

Market Cap

726.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MATW
ANNX
Founded
1850
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
639.2M
726.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MATW
ANNX
Price
$19.29
$4.05
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
★ $31.33
$17.00
AVG Volume (30 Days)
670.0K
★ 3.5M
Earning Date
11-19-2026
11-13-2026
Dividend Yield
★ 5.27%
N/A
EPS Growth
★ 59.07
N/A
EPS
★ N/A
N/A
Revenue
★ $1,795,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$18.42
$2.54
52 Week High
$30.93
$7.18

Technical Indicators

Market Signals
Indicator
MATW
ANNX
Relative Strength Index (RSI) 48.03 52.31
Support Level $18.58 $3.71
Resistance Level $19.72 $4.07
Average True Range (ATR) 0.45 0.26
MACD 0.11 0.06
Stochastic Oscillator 73.90 82.26

Price Performance

Historical Comparison
MATW
ANNX

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: